Trabecular Bone Score Improves Fracture Risk Discrimination in Postmenopausal Rheumatoid Arthritis Patients Receiving Glucocorticoids
Ratthanin Ruangnopparut,Suranut Charoensri,Dueanchonnee Sribenjalak,Daris Theerakulpisut,Chatlert Pongchaiyakul
DOI: https://doi.org/10.2147/ijgm.s448659
IF: 2.145
2024-01-27
International Journal of General Medicine
Abstract:Ratthanin Ruangnopparut, 1 Suranut Charoensri, 2 Dueanchonnee Sribenjalak, 2 Daris Theerakulpisut, 3 Chatlert Pongchaiyakul 2 1 Department of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand; 2 Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand; 3 Division of Nuclear Medicine, Department of Radiology, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand Correspondence: Suranut Charoensri, Division of Endocrinology and Metabolism, Department of Medicine, Faculty of Medicine, Khon Kaen University, Khon Kaen, 40002, Thailand, Email Background: Bone mineral density (BMD) might not be a sensitive tool for predicting osteoporotic fracture risk among patients with rheumatoid arthritis (RA), especially when receiving glucocorticoids. Trabecular bone score (TBS), which has emerged as a new assessment technique representing bone microarchitecture and strength, may be considered an alternative approach. Materials and Methods: In this cross-sectional analytical study, postmenopausal RA patients receiving glucocorticoids were identified from the postmenopause BMD database. The database included clinical data of postmenopausal outpatients who had at least one BMD measurement between January 2014 and December 2017. TBS was calculated from lumbar spine BMD with the microarchitecture assessment software. The presence of osteoporotic fractures, either vertebral or non-vertebral, was identified at the time of BMD measurement. Results: A total of 64 postmenopausal RA patients receiving glucocorticoids were included. The TBS values were inversely associated with osteoporotic fractures, with a TBS cut-off of less than 1.24, showing the best accuracy with a sensitivity of 79% and a specificity of 84% in discriminating fractures. This newly proposed TBS threshold combined with a BMD T-score of − 2.5 or less demonstrated a greater area under receiver operating characteristic curve in identifying patients with osteoporotic fractures than the BMD threshold alone ( p value = 0.003). Conclusion: The reduction in TBS was associated with an osteoporotic fracture in postmenopausal RA patients receiving glucocorticoids. Combining TBS and BMD in these patients incrementally improves fracture risk discrimination and may serve as a supplementary tool in identifying patients at greatest risk of osteoporotic fracture. Keywords: bone mineral density, trabecular bone score, osteoporotic fractures, rheumatoid arthritis, glucocorticoids Osteoporosis is an important problem in the elderly, particularly among postmenopausal women. It is characterized by the deterioration of bone mass and microarchitecture, which subsequently elevates the risk of osteoporotic fractures and associated complications. 1,2 Rheumatoid arthritis (RA) is one of the major risk factors of osteoporosis due to chronic inflammation, limitation of mobility, and concomitant glucocorticoid treatment. Patients with RA are more susceptible to developing skeletal consequences, including osteoporotic fracture, than those without RA. 3,4 Bone mineral density (BMD), measured by dual-energy X-ray absorptiometry (DXA), serves as a diagnostic tool for osteoporosis. 5 However, some patients exhibit increased fracture risk despite having normal BMD, 6 especially in those receiving chronic glucocorticoid therapy. 7 The rapid onset of bone loss and increased fragility fracture is observed when glucocorticoid therapy is initiated, and these risks escalate with higher doses and longer durations of treatment. 8,9 It is important to note that glucocorticoids have an impact on fracture risk that is independent of BMD. 10 Therefore, relying solely on BMD measurements is not the most effective way to predict fracture risk in glucocorticoid-induced osteoporosis. In recent years, advancements in bone strength assessment have led to the introduction of a new software tool called trabecular bone score (TBS) for evaluating bone microarchitecture. 11–13 TBS measures texture variations in DXA images and can be computed automatically from BMD measurements using specialized software installed on DXA machines. Previous studies have demonstrated a strong correlation between TBS and the incidence of osteoporotic fractures in various conditions, such as diabetes mellitus, chronic kidney disease, primary hyperparathyroidism, Cushing's syndrome, and ankylosing spondylitis. 14–19 Moreover, previous research suggests that patients with rheumatoid arthritis (RA) exhibit lower TBS values and an elevated risk of vertebral fractures, 20 and c -Abstract Truncated-
medicine, general & internal